Warning letterFDA · Jan 16, 2025
Mihon Corp. d/b/a VitalityVita and Boulla, LLC MARCS-CMS 698165, January 16, 2025
Named company: Mihon Corp. d/b/a VitalityVita and Boulla, LLC
As described below, these products are unapproved new drugs introduced or delivered for introduction into interstate commerce in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and…
Lot information: not specified in this record.